EllieMD
US$ 26.80
retatrutide type 2 diabetes trial results 2024 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in Phase 3 New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Retatrutide Results: 28.3% Weight Loss
Description
Weight regain after discontinuation is a major concern with all GLP-1 medications
GIP: glucose-dependent insulinotropic polypeptide
Activation of the GLP-1 pathways decreases the inflammatory response in multiple models
NutriScore by Health Goals PERSONALIZED NUTRITION Track your meals with NutriScan for personalized NutriScores based on your specific health goals
Given its biological effects, activation of GLP-1R has been explored as a latent treatment for metabolic disorders like type 2 diabetes mellitus (T2DM) and obesity
Velji-Ibrahim J, et al
